Navigation Links
Alzheimer substance may be the nanomaterial of tomorrow
Date:12/16/2013

Amyloid protein causes diseases like Alzheimer's, Parkinson's and Creutzfeldt-Jakob disease. But amyloid also carries unique characteristics that may lead to the development of new composite materials for the nano processors and data storage of tomorrow, and even make objects invisible.

Researchers from Chalmers University of Technology recently unveiled an unexpected discovery about amyloid in an article published in the Nature Photonics journal. Amyloids are misfolded variants of proteins that occur naturally in the body. The researchers have now shown that the misfolded variants react to multiphoton irradiation, a type of laser effect, whereas the healthy proteins do not.

The discovery could be useful in a variety of fields. Not only can it lead to new methods to detect and treat the brain diseases that amyloid causes (see earlier press release below), amyloid may also be used as a building block for future nanomaterials.

"It is possible to create these protein aggregates artificially in a laboratory", says Piotr Hanczyc, one of the researchers who made the discovery. "By combining them with other molecules, one could create materials with unique characteristics."

The amyloid aggregates are as hard and rigid as steel. The difference is that steel is much heavier and has defined material properties, whereas amyloids can be tuned for specific purposes. By attaching a material's molecules to the dense amyloid, its characteristics change.

"This was already known, but what has not been known is that the amyloids react to multiphoton irradiation", says Piotr Hanczyc. "This opens up new possibilities to also change the nature of the material attached to the amyloids."

The amyloids are shaped like discs, densely piled upon each other. When a material gets merged with these discs, its molecules end up so densely and regularly placed that they can communicate and exchange information. This means completely n
'/>"/>

Contact: Johanna Wilde
johanna.wilde@chalmers.se
46-317-722-029
Chalmers University of Technology
Source:Eurekalert  

Page: 1 2

Related biology news :

1. New hope for treating Alzheimers Disease: A role for the FKBP52 protein
2. Amyloid beta in the brain of individuals with Alzheimers disease
3. A new gene thought to be the cause in early-onset forms of Alzheimers disease
4. Antioxidant may disrupt Alzheimers disease process
5. Clinical trials for Alzheimers disease preventative drug to begin early 2013
6. Grant program to spur new research on Alzheimers disease by encouraging collaboration
7. VTT and GE Healthcare developing novel biomarkers to predict Alzheimers disease
8. Exercise is key in the fight against Alzheimers disease
9. Chronic inflammation in the brain leads the way to Alzheimers disease
10. Revolutionary project will obtain entire genome sequences in fight against Alzheimers
11. Small molecule may play big role in Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Alzheimer substance may be the nanomaterial of tomorrow
(Date:7/11/2014)... Conservation Society shows that no-take zones in Belize ... as lobster, conch, and fish recover from overfishing, ... , The reporttitled "Review of the Benefits of ... from no-take areas around the world. The report ... expert in marine protected areas and fisheries management. ...
(Date:7/11/2014)... at the Department of Energy,s Oak Ridge National ... by R&D Magazine in recognition of the year,s ... the tremendous value of our National Labs," said ... at the National Labs continues to help our ... scientific and technological innovations necessary to remain globally ...
(Date:7/11/2014)... in eastern New South Wales, Australia when NASA,s Aqua ... UTC on July 11 (12:35 p.m. local time/11:35 p.m. ... New South Wales (NSW), the Moderate Resolution Imaging Spectroradiometer ... region and spotted smoke (light brown) from various fires. ... outlined in red. , The New South Wales, Australia ...
Breaking Biology News(10 mins):Belize's lobster, conch, and fish populations rebuild in no-take zones 2ORNL wins eight R&D 100s 2ORNL wins eight R&D 100s 3ORNL wins eight R&D 100s 4
... new study finds that propofol, a well-known anesthesia medication, has ... imaging studies. The study, led by a pediatric anesthesiologist now ... incidence of adverse events and no long term complications when ... require them to be still for long periods of time. ...
... life, and occurs naturally in soil and ground water in ... been linked to lung, bladder and kidney cancer, and thus ... drinking water. Chemically similar to phosphorus, arsenic forms arsenate (AsO ... 3- ). Arsenate interferes with many phosphate-requiring metabolic reactions, ...
... June 8, 2010 From April 8 to 10, ... Texas, to focus on advancing new tools to humanely ... and dogs. Experts in reproductive biology and other related ... with industry experts in animal health drug development. Veterinary ...
Cached Biology News:Propofol poses low risk in pediatric imaging studies, but risk increases with anesthesia duration 2Arsenic hyperaccumulating ferns: How do they survive? 2Arsenic hyperaccumulating ferns: How do they survive? 3Momentum builds after 4th International Symposium on Pet Contraception 2Momentum builds after 4th International Symposium on Pet Contraception 3
(Date:7/10/2014)... (PRWEB) July 10, 2014 Robert Harman, DVM, ... Medicine company, is proud to announce the relaunch of his ... with a new series called “ What are Stem Cells ... an honest and straightforward foundation in the basics of stem ... decision on the right type of treatment when considering regenerative ...
(Date:7/10/2014)... Senior supply chain management executives from ... the challenges of “Reducing Cost, Lead Time, & Defects ... sourcing. Describing the partnership of the Bio Supply Management ... Institute ( SCMI) of the University of San ... the Kroc Institute of Peace and Justice in San ...
(Date:7/10/2014)... 2014  Kainos Capital, a firm specializing in acquiring ... it has acquired the Slim-Fast brand from Unilever. Unilever ... of the transaction were not disclosed. Slim-Fast ... that markets ready-to-drink shakes, powders, bars and snacks to ... and in the United Kingdom ...
(Date:7/10/2014)... 10, 2014   Ceres, Inc . (Nasdaq: ... announced today financial results for the three months ended ... business. Ceres reported that the company and ... this growing season in Brazil, which concluded in June, ... sorghum evaluation areas for part of the growing season. ...
Breaking Biology Technology:Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 2Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 4Kainos Capital Acquires Slim-Fast From Unilever 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 3Ceres Announces Fiscal Third Quarter 2014 Financial Results 4Ceres Announces Fiscal Third Quarter 2014 Financial Results 5Ceres Announces Fiscal Third Quarter 2014 Financial Results 6Ceres Announces Fiscal Third Quarter 2014 Financial Results 7Ceres Announces Fiscal Third Quarter 2014 Financial Results 8Ceres Announces Fiscal Third Quarter 2014 Financial Results 9
... , , , NEW ... of lipid, glucose and overall energy metabolism. Bile acid activation of the ... muscle and brown fat, thereby conferring resistance to weight gain. Now, a ... 10, Issue 3, Sept. 2, 2009) elaborates on a separate TGR5-regulated mechanism ...
... WOODLANDS, Texas, September 1 Berlin Heart Inc.,reported today that ... EXCOR(R) Pediatric IDE Study after having received unconditional,approval of the ... The Principal Investigator, Dr. Charles Fraser, Chief of ... and Pediatrics,at Baylor College of Medicine said, "We ...
... ST. LOUIS and ROMAINVILLE, France, Sept. 1, 2009 Monsanto Company ... commercial license agreement with France-based Cellectis S.A. (Alternext: ALCLS), a biotechnology ... technology in plants. , , Meganucleases are molecular ... genome of a plant cell, thereby allowing a wide range of ...
Cached Biology Technology:Cell Metabolism Publishes Novel TGR5-Mediated Mechanism for the Treatment of Diabetes and Obesity 2Cell Metabolism Publishes Novel TGR5-Mediated Mechanism for the Treatment of Diabetes and Obesity 3Major Milestone Achieved - Berlin Heart EXCOR Pediatric IDE Study 2Monsanto Licenses Use of Cellectis' Innovative Genome Modification Technology 2Monsanto Licenses Use of Cellectis' Innovative Genome Modification Technology 3